Cargando…
PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer
BACKGROUND: PLOD2 is overexpressed in diverse tumors and plays a vital role in tumorigenesis. However, the prognostic value of PLOD2 in cervical cancer (CESC) remains unclear. METHODS: PLOD2 expression and CESC patients' survival data were collected from the Oncomine, GEPIA, UALCAN, and Kaplan-...
Autores principales: | Li, Guang, Wang, Xuefeng, Liu, Guobing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260295/ https://www.ncbi.nlm.nih.gov/pubmed/34258263 http://dx.doi.org/10.1155/2021/5512340 |
Ejemplares similares
-
Corrigendum to “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer”
por: Li, Guang, et al.
Publicado: (2021) -
PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma
por: Wang, Zhen, et al.
Publicado: (2022) -
PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma
por: Deng, Xianyu, et al.
Publicado: (2021) -
PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression
por: Kreße, Nina, et al.
Publicado: (2022) -
PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022)